FeaturedAs U.K. Authorizes Pfizer Vaccine, Biotech ETFs Continue to RallyBy Ian YoungDecember 3, 2020
Equity ETF ChannelBiotech ETFs Poised for Gains after Moderna Vaccine NewsBy Ian YoungNovember 16, 2020
Innovative ETFs ChannelBiotech ETFs Strengthen as Amgen Invests in China’s BeiGeneBy Max ChenNovember 1, 2019
Innovative ETFs ChannelHealthcare, Biotech ETFs XLV and XBI Slide on FDA’s Uncertain OutlookBy Max ChenMarch 6, 2019
Innovative ETFs ChannelSpecialized Biotech ETF Rallies on MacroGenics Positive Trial ResultsBy Max ChenFebruary 6, 2019
